OPTION-EMEA Clinical Trial
Eligible age
18+ yrs
Accepts
All genders
Locations
0 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The OPTION-EMEA post-market study is intended to gather real world clinical data for patients undergoing AF ablation with the FARAPULSE™ Pulsed Field Ablation (PFA) System and subsequent left atrial appendage closure (LAAC) with a WATCHMAN FLX™ Pro or WATCHMAN FLX device during one interventional case. The study will include patients that are clinically indicated for atrial fibrillation (AF) ablation using the FARAPULSE PFA System and for left atrial appendage closure (LAAC) treatment using a WATCHMAN FLX Pro or WATCHMAN FLX device as part of the patient's standard of care determined by their doctor's medical judgement.
Sponsor: Boston Scientific Corporation
You may qualify if…
- ✓ 1. Clinically indicated for treatment with both the FARAPULSE™ PFA system and with WATCHMAN FLX™ Pro or WATCHMAN FLX™ for LAAC, per physician medical judgement and as per hospitals' standard of care.
- ✓ 2. Subjects who are willing and able to provide informed consent.
- ✓ 3. Subjects who are willing and able to participate in all testing associated with this clinical study at an approved investigational center.
- ✓ 4. Subjects whose age is 18 years or above, or who are of legal age to give informed consent specific to state and national law.
You may not qualify if…
- ✕ 1. Subjects who underwent prior AF ablation procedure.
- ✕ 2. Subjects with atrial fibrillation that is secondary to electrolyte imbalance, thyroid disease, alcohol, or other reversible / non-cardiac causes.
- ✕ 3. Already surgically closed or otherwise excluded LAA.
- ✕ 4. The LAA anatomy does not accommodate a Closure Device.
- ✕ 5. Known or suspected atrial myxoma.
- ✕ 6. Presence of intracardiac thrombus\*.
- ✕ 7. Subjects with a current interatrial baffle or patch, history of atrial septal repair or has an atrial septal defect (ASD) / patent foramen ovale (PFO) device.
- ✕ 8. Subjects with a presence of a mechanical valve prosthesis in any position.
Source: ClinicalTrials.gov · NCT07349121 · last updated 2026-09-11